Renaissance Technologies’s Perspective Therapeutics CATX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-163,460
| Closed | -$348K | – | 3582 |
|
|
2025
Q1 | $348K | Buy |
+163,460
| New | +$348K | ﹤0.01% | 2870 |
|
|
2024
Q3 | – | Sell |
-61,660
| Closed | -$615K | – | 3552 |
|
|
2024
Q2 | $615K | Buy |
61,660
+58,485
| +1,842% | +$583K | ﹤0.01% | 2599 |
|
|
2024
Q1 | $38K | Sell |
3,175
-27,500
| -90% | -$329K | ﹤0.01% | 3522 |
|
|
2023
Q4 | $123K | Sell |
30,675
-6,090
| -17% | -$24.4K | ﹤0.01% | 3252 |
|
|
2023
Q3 | $101K | Sell |
36,765
-6,928
| -16% | -$19K | ﹤0.01% | 3239 |
|
|
2023
Q2 | $292K | Buy |
43,693
+2,040
| +5% | +$13.6K | ﹤0.01% | 3136 |
|
|
2023
Q1 | $266K | Buy |
41,653
+3,740
| +10% | +$23.9K | ﹤0.01% | 3166 |
|
|
2022
Q4 | $94K | Buy |
37,913
+700
| +2% | +$1.74K | ﹤0.01% | 3640 |
|
|
2022
Q3 | $86K | Sell |
37,213
-496
| -1% | -$1.15K | ﹤0.01% | 3639 |
|
|
2022
Q2 | $117K | Sell |
37,709
-4,023
| -10% | -$12.5K | ﹤0.01% | 3807 |
|
|
2022
Q1 | $151K | Sell |
41,732
-56,359
| -57% | -$204K | ﹤0.01% | 3716 |
|
|
2021
Q4 | $380K | Sell |
98,091
-21,272
| -18% | -$82.4K | ﹤0.01% | 3226 |
|
|
2021
Q3 | $753K | Sell |
119,363
-138,667
| -54% | -$875K | ﹤0.01% | 2700 |
|
|
2021
Q2 | $2.06M | Sell |
258,030
-67,993
| -21% | -$543K | ﹤0.01% | 2244 |
|
|
2021
Q1 | $3.55M | Buy |
326,023
+191,170
| +142% | +$2.08M | ﹤0.01% | 1861 |
|
|
2020
Q4 | $607K | Buy |
134,853
+83,783
| +164% | +$377K | ﹤0.01% | 2736 |
|
|
2020
Q3 | $298K | Sell |
51,070
-56,735
| -53% | -$331K | ﹤0.01% | 2999 |
|
|
2020
Q2 | $599K | Buy |
107,805
+39,389
| +58% | +$219K | ﹤0.01% | 2805 |
|
|
2020
Q1 | $363K | Buy |
68,416
+43,761
| +177% | +$232K | ﹤0.01% | 2902 |
|
|
2019
Q4 | $154K | Buy |
+24,655
| New | +$154K | ﹤0.01% | 3241 |
|